Cargando…

Image-based modeling of vascular organization to evaluate anti-angiogenic therapy

In tumor therapy anti-angiogenic approaches have the potential to increase the efficacy of a wide variety of subsequently or co-administered agents, possibly by improving or normalizing the defective tumor vasculature. Successful implementation of the concept of vascular normalization under anti-ang...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascheid, David, Baumann, Magdalena, Funke, Caroline, Volz, Julia, Pinnecker, Jürgen, Friedrich, Mike, Höhn, Marie, Nandigama, Rajender, Ergün, Süleyman, Nieswandt, Bernhard, Heinze, Katrin G., Henke, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018970/
https://www.ncbi.nlm.nih.gov/pubmed/36922848
http://dx.doi.org/10.1186/s13062-023-00365-x
_version_ 1784907924485701632
author Ascheid, David
Baumann, Magdalena
Funke, Caroline
Volz, Julia
Pinnecker, Jürgen
Friedrich, Mike
Höhn, Marie
Nandigama, Rajender
Ergün, Süleyman
Nieswandt, Bernhard
Heinze, Katrin G.
Henke, Erik
author_facet Ascheid, David
Baumann, Magdalena
Funke, Caroline
Volz, Julia
Pinnecker, Jürgen
Friedrich, Mike
Höhn, Marie
Nandigama, Rajender
Ergün, Süleyman
Nieswandt, Bernhard
Heinze, Katrin G.
Henke, Erik
author_sort Ascheid, David
collection PubMed
description In tumor therapy anti-angiogenic approaches have the potential to increase the efficacy of a wide variety of subsequently or co-administered agents, possibly by improving or normalizing the defective tumor vasculature. Successful implementation of the concept of vascular normalization under anti-angiogenic therapy, however, mandates a detailed understanding of key characteristics and a respective scoring metric that defines an improved vasculature and thus a successful attempt. Here, we show that beyond commonly used parameters such as vessel patency and maturation, anti-angiogenic approaches largely benefit if the complex vascular network with its vessel interconnections is both qualitatively and quantitatively assessed. To gain such deeper insight the organization of vascular networks, we introduce a multi-parametric evaluation of high-resolution angiographic images based on light-sheet fluorescence microscopy images of tumors. We first could pinpoint key correlations between vessel length, straightness and diameter to describe the regular, functional and organized structure observed under physiological conditions. We found that vascular networks from experimental tumors diverted from those in healthy organs, demonstrating the dysfunctionality of the tumor vasculature not only on the level of the individual vessel but also in terms of inadequate organization into larger structures. These parameters proofed effective in scoring the degree of disorganization in different tumor entities, and more importantly in grading a potential reversal under treatment with therapeutic agents. The presented vascular network analysis will support vascular normalization assessment and future optimization of anti-angiogenic therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13062-023-00365-x.
format Online
Article
Text
id pubmed-10018970
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100189702023-03-17 Image-based modeling of vascular organization to evaluate anti-angiogenic therapy Ascheid, David Baumann, Magdalena Funke, Caroline Volz, Julia Pinnecker, Jürgen Friedrich, Mike Höhn, Marie Nandigama, Rajender Ergün, Süleyman Nieswandt, Bernhard Heinze, Katrin G. Henke, Erik Biol Direct Research In tumor therapy anti-angiogenic approaches have the potential to increase the efficacy of a wide variety of subsequently or co-administered agents, possibly by improving or normalizing the defective tumor vasculature. Successful implementation of the concept of vascular normalization under anti-angiogenic therapy, however, mandates a detailed understanding of key characteristics and a respective scoring metric that defines an improved vasculature and thus a successful attempt. Here, we show that beyond commonly used parameters such as vessel patency and maturation, anti-angiogenic approaches largely benefit if the complex vascular network with its vessel interconnections is both qualitatively and quantitatively assessed. To gain such deeper insight the organization of vascular networks, we introduce a multi-parametric evaluation of high-resolution angiographic images based on light-sheet fluorescence microscopy images of tumors. We first could pinpoint key correlations between vessel length, straightness and diameter to describe the regular, functional and organized structure observed under physiological conditions. We found that vascular networks from experimental tumors diverted from those in healthy organs, demonstrating the dysfunctionality of the tumor vasculature not only on the level of the individual vessel but also in terms of inadequate organization into larger structures. These parameters proofed effective in scoring the degree of disorganization in different tumor entities, and more importantly in grading a potential reversal under treatment with therapeutic agents. The presented vascular network analysis will support vascular normalization assessment and future optimization of anti-angiogenic therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13062-023-00365-x. BioMed Central 2023-03-15 /pmc/articles/PMC10018970/ /pubmed/36922848 http://dx.doi.org/10.1186/s13062-023-00365-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ascheid, David
Baumann, Magdalena
Funke, Caroline
Volz, Julia
Pinnecker, Jürgen
Friedrich, Mike
Höhn, Marie
Nandigama, Rajender
Ergün, Süleyman
Nieswandt, Bernhard
Heinze, Katrin G.
Henke, Erik
Image-based modeling of vascular organization to evaluate anti-angiogenic therapy
title Image-based modeling of vascular organization to evaluate anti-angiogenic therapy
title_full Image-based modeling of vascular organization to evaluate anti-angiogenic therapy
title_fullStr Image-based modeling of vascular organization to evaluate anti-angiogenic therapy
title_full_unstemmed Image-based modeling of vascular organization to evaluate anti-angiogenic therapy
title_short Image-based modeling of vascular organization to evaluate anti-angiogenic therapy
title_sort image-based modeling of vascular organization to evaluate anti-angiogenic therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018970/
https://www.ncbi.nlm.nih.gov/pubmed/36922848
http://dx.doi.org/10.1186/s13062-023-00365-x
work_keys_str_mv AT ascheiddavid imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT baumannmagdalena imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT funkecaroline imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT volzjulia imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT pinneckerjurgen imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT friedrichmike imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT hohnmarie imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT nandigamarajender imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT ergunsuleyman imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT nieswandtbernhard imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT heinzekatring imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy
AT henkeerik imagebasedmodelingofvascularorganizationtoevaluateantiangiogenictherapy